Randomized Phase II Trial (Portside) Evaluating Encorafenib (Enco) And Binimetinib (Bini) Plus Pembrolizumab (Pembro) Versus Nivolumab (Nivo) And Ipilimumab (Ipi) For The Treatment Of Advanced Braf-Mutant Melanoma
Binimetinib;Encorafenib;Pembrolizumab;Ipilimumab;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Randomized Phase II Trial (Portside) Evaluating Encorafenib (Enco) And Binimetinib (Bini) Plus Pembrolizumab (Pembro) Versus Nivolumab (Nivo) And Ipilimumab (Ipi) For The Treatment Of Advanced Braf-Mutant Melanoma ### Output: Binimetinib;Encorafenib;Pembrolizumab;Ipilimumab;Nivolumab